Clinical Trials on Hematologic Malignancies in United Kingdom
Total 8378 results
-
Masonic Cancer Center, University of MinnesotaCompleted
-
Rafic Farah, MDCompletedLymphoma | Leukemia | Myelofibrosis | MDSUnited States
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | Hematopoietic/Lymphoid CancerUnited States
-
Spirita Oncology, LLCTerminatedAML | MDS | CMMLUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Myeloma | Hematological MalignancyUnited States
-
Terumo BCTbioBiomedical Advanced Research and Development AuthorityTerminatedHematologic Malignancies | Hypoproliferative ThrombocytopeniaUnited States
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited Kingdom
-
M.D. Anderson Cancer CenterTerminatedFatigue | Advanced Cancer | Hematologic MalignancyUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Hematologic MalignanciesUnited States
-
Dana-Farber Cancer InstituteTerminated
-
Medical College of WisconsinRecruitingMultiple Myeloma | Hematological MalignancyUnited States
-
Wake Forest University Health SciencesCompletedLymphoma | LeukemiaUnited States
-
Medical College of WisconsinTerminatedLymphoma | Myelodysplastic Syndromes | Acute Leukemia | Chronic LeukemiaUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingMDS | Leukemia, AcuteUnited States
-
Fred Hutchinson Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI)CompletedAssociations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of LifeHematologic Malignancies | Other Diagnoses, Comorbidities, and ComplicationsUnited States
-
University of ChicagoCompletedLymphoma | Leukemia | MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.CompletedHematologic Malignancy | Myeloproliferative DisorderUnited States
-
Gilead SciencesCompletedRelapsed/Refractory B-cell MalignanciesFrance, United Kingdom
-
Masonic Cancer Center, University of MinnesotaTerminatedHematologic MalignancyUnited States
-
BioInvent International ABMerck Sharp & Dohme LLCRecruitingAdvanced MalignanciesUnited Kingdom, Denmark, Hungary, Russian Federation
-
PfizerCompletedSolid Tumor and Hematologic MalignanciesUnited States
-
Nelson ChaoNational Center for Advancing Translational Sciences (NCATS); Mereo BioPharmaWithdrawnHematologic MalignancyUnited States
-
PCI Biotech ASCompletedCutaneous or Sub-cutaneous MalignanciesUnited Kingdom
-
Dartmouth-Hitchcock Medical CenterCompletedHematologic MalignanciesUnited States
-
National Cancer Institute (NCI)Suspended
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI); National Institutes of Health (NIH)Withdrawn
-
M.D. Anderson Cancer CenterAccess Pharmaceuticals, Inc.Completed
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.Completed
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...CompletedHematologic Malignancies | Graft Versus Host DiseaseUnited States
-
Nationwide Children's HospitalActive, not recruitingHematologic Malignancy | MyelodysplasiaUnited States
-
AbbVieCompletedCancer | Advanced Solid Tumors | Hematologic MalignanciesUnited States, Japan, Netherlands, Spain
-
Pavan Reddy, MDCompletedGraft vs Host Disease | Hematologic MalignanciesUnited States
-
Kiadis PharmaCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeCanada, Germany, Belgium, United Kingdom
-
University of Colorado, DenverBioIntelliSense, IncActive, not recruitingHematologic MalignancyUnited States
-
Sumitomo Pharma America, Inc.CompletedHematologic MalignancyUnited States
-
University College, LondonCompletedCD19+ Malignancies: Relapse Post-allogeneic TransplantUnited Kingdom
-
Masonic Cancer Center, University of MinnesotaTerminatedAML | MDS | Leukemia, Lymphocytic, AcuteUnited States
-
Matthew DallosBristol-Myers SquibbTerminatedSolid Tumor | Sars-CoV2 | Hematological MalignancyUnited States
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingHematologic MalignanciesUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
University College, LondonActive, not recruitingBurkitt Lymphoma | Acute Lymphoblastic LeukemiaUnited Kingdom
-
Prescient Therapeutics, Ltd.VioQuest PharmaceuticalsCompletedLeukemia | Hematologic MalignanciesUnited States
-
Gilead SciencesActive, not recruitingB-cell MalignanciesUnited States, United Kingdom, France
-
Tarix PharmaceuticalsWithdrawnHematologic MalignanciesUnited States
-
Center for International Blood and Marrow Transplant...CompletedHematologic Malignancies | Cord Blood Stem Cell TransplantationUnited States
-
Janssen Research & Development, LLCActive, not recruitingHematological MalignanciesCanada, United States, France, Italy, United Kingdom, Germany, Belgium, Netherlands, Spain, Sweden, China
-
Massachusetts General HospitalTerminatedRefractory Lymphoma | Hematologic MalignancyUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Institutes of Health (NIH)CompletedHematologic Malignancies | Graft-Versus-Host DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHematologic Malignancies | Bone Marrow Transplant RejectionUnited States
-
M.D. Anderson Cancer CenterEnzon Pharmaceuticals, Inc.CompletedInvasive Fungal Infections | Hematologic MalignanciesUnited States